Relationship of CYP2D6 status and toremifene metabolism

被引：1
|
作者：
Kim, J. [1 ]
Dalton, J. T. [1 ]
Veverka, K. A. [1 ]
机构：
[1] GTx Inc, Memphis, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e13068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13068
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans
    Bottiger, Y
    Dostert, P
    Benedetti, MS
    Bani, M
    Fiorentini, F
    Casati, M
    Poggesti, I
    Alm, C
    Alvan, G
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (06) : 707 - 711
  • [42] Quantitative assessment of the effect of CYP2D6 genotype on tamoxifen metabolism: A model for CYP2D6 genotype-phenotype studies.
    Borges, S
    Desta, Z
    Jin, Y
    Li, L
    Skaar, TC
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P34 - P34
  • [43] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [44] Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients
    Haslemo, Tore
    Eliasson, Erik
    Jukic, Marin M.
    Ingelman-Sundberg, Magnus
    Molden, Espen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (01) : 194 - 201
  • [45] Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism
    Lewis, DFV
    Eddershaw, PJ
    Goldfarb, PS
    Tarbit, MH
    XENOBIOTICA, 1997, 27 (04) : 319 - 339
  • [46] Evaluation of 24 CYP2D6 Variants on the Metabolism of Nebivolol In Vitro
    Hu, Xiaoxia
    Lan, Tian
    Dai, Dapeng
    Xu, Ren-ai
    Yuan, Lingjing
    Zhou, Quan
    Li, Yunxuan
    Cai, Jianping
    Hu, Guoxin
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (11) : 1828 - 1831
  • [47] Response to "Understanding CYP2D6 and Its Role in Tamoxifen Metabolism"
    Kaplan, Marcelle
    Mahon, Suzanne M.
    ONCOLOGY NURSING FORUM, 2014, 41 (01) : 12 - 12
  • [48] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [49] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4
    O. Monek
    G. Paintaud
    Y. Bechtel
    J. P. Miguet
    G. Mantion
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 1998, 54 : 47 - 52
  • [50] CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia
    Ballester, Pura
    Muriel, Javier
    Peiro, Ana M.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (04) : 261 - 275
12345